Chen J - Search Results

1

Regulation of mammary gland branching morphogenesis by EphA2 receptor tyrosine kinase.

Vaught D, Chen J, Brantley-Sieders DM. Vaught D, et al. Among authors: chen j. Mol Biol Cell. 2009 May;20(10):2572-81. doi: 10.1091/mbc.e08-04-0378. Epub 2009 Mar 25. Mol Biol Cell. 2009. PMID: 19321667 Free PMC article.

2

Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.

Cheng N, Brantley DM, Liu H, Lin Q, Enriquez M, Gale N, Yancopoulos G, Cerretti DP, Daniel TO, Chen J. Cheng N, et al. Among authors: chen j. Mol Cancer Res. 2002 Nov;1(1):2-11. Mol Cancer Res. 2002. PMID: 12496364

3

EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation.

Brantley-Sieders DM, Caughron J, Hicks D, Pozzi A, Ruiz JC, Chen J. Brantley-Sieders DM, et al. Among authors: chen j. J Cell Sci. 2004 Apr 15;117(Pt 10):2037-49. doi: 10.1242/jcs.01061. Epub 2004 Mar 30. J Cell Sci. 2004. PMID: 15054110

4

Eph receptor tyrosine kinases in angiogenesis: from development to disease.

Brantley-Sieders DM, Chen J. Brantley-Sieders DM, et al. Among authors: chen j. Angiogenesis. 2004;7(1):17-28. doi: 10.1023/B:AGEN.0000037340.33788.87. Angiogenesis. 2004. PMID: 15302992 Review.

5

Eph receptor tyrosine kinases in tumor and tumor microenvironment.

Brantley-Sieders D, Schmidt S, Parker M, Chen J. Brantley-Sieders D, et al. Among authors: chen j. Curr Pharm Des. 2004;10(27):3431-42. doi: 10.2174/1381612043383160. Curr Pharm Des. 2004. PMID: 15544526 Review.

6

EphA2 receptor tyrosine kinase as a promising target for cancer therapeutics.

Ireton RC, Chen J. Ireton RC, et al. Among authors: chen j. Curr Cancer Drug Targets. 2005 May;5(3):149-57. doi: 10.2174/1568009053765780. Curr Cancer Drug Targets. 2005. PMID: 15892616 Review.

7

A kinase-dependent role for EphA2 receptor in promoting tumor growth and metastasis.

Fang WB, Brantley-Sieders DM, Parker MA, Reith AD, Chen J. Fang WB, et al. Among authors: chen j. Oncogene. 2005 Nov 24;24(53):7859-68. doi: 10.1038/sj.onc.1208937. Oncogene. 2005. PMID: 16103880

8

Impaired tumor microenvironment in EphA2-deficient mice inhibits tumor angiogenesis and metastatic progression.

Brantley-Sieders DM, Fang WB, Hicks DJ, Zhuang G, Shyr Y, Chen J. Brantley-Sieders DM, et al. Among authors: chen j. FASEB J. 2005 Nov;19(13):1884-6. doi: 10.1096/fj.05-4038fje. Epub 2005 Sep 15. FASEB J. 2005. PMID: 16166198

9

Inhibition of retinal neovascularization by soluble EphA2 receptor.

Chen J, Hicks D, Brantley-Sieders D, Cheng N, McCollum GW, Qi-Werdich X, Penn J. Chen J, et al. Exp Eye Res. 2006 Apr;82(4):664-73. doi: 10.1016/j.exer.2005.09.004. Epub 2005 Dec 15. Exp Eye Res. 2006. PMID: 16359662

10

Essential role of Vav family guanine nucleotide exchange factors in EphA receptor-mediated angiogenesis.

Hunter SG, Zhuang G, Brantley-Sieders D, Swat W, Cowan CW, Chen J. Hunter SG, et al. Among authors: chen j. Mol Cell Biol. 2006 Jul;26(13):4830-42. doi: 10.1128/MCB.02215-05. Mol Cell Biol. 2006. PMID: 16782872 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

135,996 results

Search Page

Filters